Annual balance sheet for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2,372 | 2,829 | 3,604 | 3,293 | 4,036 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,594 | 792 | 1,270 | 2,354 | 2,309 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,459 | 7,318 | 8,246 | 8,958 | 11,409 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,914 | 7,017 | 7,918 | 8,828 | 8,771 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 16,370 | 17,350 | 19,311 | 21,195 | 22,848 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,446 | 4,471 | 4,144 | 4,818 | 5,182 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10,482 | 10,562 | 10,816 | 12,054 | 13,600 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,888 | 6,788 | 8,495 | 9,141 | 9,248 |
| Total Liabilities & Shareholders' Equity | 16,370 | 17,350 | 19,311 | 21,195 | 22,848 |
| Total Common Shares Outstanding |